Medicine
CRISPR news, research, studies, and rapid health briefings. Visit Viral Vitalism for plain-language context, evidence boundaries, and related signals.
News cycle
A young actress and Spelman graduate is preparing for Casgevy after years of sickle-cell pain crises, but her treatment story is still pre-infusion.
Why now
McKenzie's story lets VV track a Casgevy journey from collection and manufacturing through infusion, rather than only covering the post-treatment headline.
Daniel Cressy's People feature adds sharper human detail: childhood hospitalizations up to 12 times a year, insurance friction, improved hemoglobin, Life 2, and a pilot-access mission.
Why now
A patient-level milestone is moving gene therapy from approval news into real-world care in Louisiana and national coverage.
A new FDA draft guidance and recent reversals suggest the biggest bottleneck in gene therapy may no longer be the science alone. It may be the approval process itself.
Why now
Draft guidance and recent reversals suggest the rare-disease rulebook is changing in real time.
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No miracle claims. Just better health signal.
By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.
